- Clone
- W20113I (See other available formats)
- Regulatory Status
- RUO
- Other Names
- AP-TNAP, TNAP, Tissue-Nonspecific ALP, APTNAP, Alkaline Phosphatase, Biomineralization Associated; Alkaline Phosphatase, Tissue-Nonspecific Enzyme (TNAP); Alkaline Phosphatase, Liver/Bone/Kidney Isozyme
- Isotype
- Rat IgG2b, κ
- Ave. Rating
- Submit a Review
- Product Citations
- publications
Cat # | Size | Price | Quantity Check Availability | Save | ||
---|---|---|---|---|---|---|
635951 | 25 µg | 132€ | ||||
635952 | 100 µg | 332€ |
ALPL is the tissue-nonspecific member of the alkaline phosphatase protein family, which includes four members: the tissue-nonspecific (liver/bone/kidney) ALP also called TNSALP, encoded by ALPL gene, and three tissue-specific ALPs that include intestinal (IAP), placental (PLAP-1), and placental-like 2 or germ cell (GCAP) ALPs; these enzymes are encoded by ALPI, ALPP, and ALPPL2 genes, respectively. Both ALPL and ALPI are expressed in many vertebrate species, while PLAP-1 and GCAP are expressed only in mammals. ALPL catalyzes the dephosphorylation of compounds in many transphosphorylation reactions. ALPL hydrolyzes monophosphated esters such as phosphoethanolamine, inorganic pyrophosphate, and pyridoxal 5′-phosphate. ALPL is a homodimeric protein and each monomer possesses 524 amino acids. It is expressed mainly in liver, bone, and kidney tissues, although it can be found in all tissues. It is typically found in a membrane bound form. Its catalytic site harbors two Zn ions and one Mg ion essential for enzyme activity. Mutations in the ALPL gene causing deficiency in ALPL activity result in hypophosphatasia and skeletal defects. ALPL regulates senescence and differentiation in mesenchymal stem cells from bone marrow. ALPL deficiency induces bone mass loss and increase in marrow fat, characteristics of premature bone ageing. ALPL was found to regulate cancer cell motility in some ovarian cancers via a non-canonical WNT pathway.
Product DetailsProduct Details
- Verified Reactivity
- Human
- Antibody Type
- Monoclonal
- Host Species
- Rat
- Immunogen
- Recombinant human ALPL protein
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide
- Preparation
- The antibody was purified by affinity chromatography.
- Concentration
- 0.5 mg/mL
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C.
- Application
-
WB - Quality tested
ICC, IP - Verified - Recommended Usage
-
Each lot of this antibody is quality control tested by western blotting. For western blotting, the suggested use of this reagent is 0.125 - 1.0 µg/mL. For immunocytochemistry, a concentration range of 1.0 - 5.0 μg/mL is recommended. For immunoprecipitation, the suggested use of this reagent is 5.0 µg/test. It is recommended that the reagent be titrated for optimal performance for each application.
- Application Notes
-
This antibody (clone W20113I) does not cross-react with mouse ALPL. This product is not suggested for use in mouse.
For immunocytochemistry (ICC), we recommend using 4% PFA fixation followed by permeabilization with 0.5% Triton X-100.
This antibody (clone W20113I) is not suitable for immunohistochemistry (IHC). - Additional Product Notes
-
This antibody (clone W20113I) has been tested in knockout/knockdown models for WB and ICC.
- RRID
-
AB_3106113 (BioLegend Cat. No. 635951)
AB_3106113 (BioLegend Cat. No. 635952)
Antigen Details
- Structure
- ALPL is a 524 amino acid protein with a predicted molecular weight of 57 kD.
- Distribution
-
Osteoblast, bone marrow mesenchymal stem cells, liver, bone, kidney
- Function
- Bone and tooth mineralization, metabolism of nucleotides, sequentially hydrolyzes ATP, ADP and AMP
- Interaction
- Monoesters of phosphoric acid, inorganic pyrophosphate, phosphoethanolamine, and pyridoxal 5′-phosphate. Interacts with the ECM, collagen
- Cell Type
- Mesenchymal Stem Cells, Osteoblasts
- Biology Area
- Cell Biology, Stem Cells
- Molecular Family
- Protein Kinases/Phosphatase
- Antigen References
-
- Weis MJ, et al. 1988. J Biol Chem. 263:12002-10.
- Kim EE and Wyckoff HW. 1991. J Mol Biol. 218:449-64.
- Mornet E. 2000. Human Mutation. 15:309-15.
- Yang Y, et al. 2012. Front Immunol. 3:314.
- Silvent J, et al. 2014. J Biol Chem. 289:24168-79.
- Liu W, et al. 2018. Bone Res. 6:27.
- Lou M, et al. 2019. Biochem Biophys Res Commun. 513:528-533.
- Gene ID
- 249 View all products for this Gene ID
- UniProt
- View information about ALPL on UniProt.org
Related Pages & Pathways
Pages
Other Formats
View All ALPL Reagents Request Custom ConjugationDescription | Clone | Applications |
---|---|---|
Purified anti-ALPL | W20113I | WB,ICC,IP |
Compare Data Across All Formats
This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.
Follow Us